--- a
+++ b/clusters/9knumclustersv2/clust_1544.txt
@@ -0,0 +1,93 @@
+Patients should have no contraindications to having a contrast enhanced MRI scan; these contraindications will be assessed at the time of enrollment using the guidelines set up and in clinical use by the Institutional Standard Practice
+Increased intracranial pressure or other contraindications to internal or external jugular venous compression.
+Known contraindications to radiotherapy including but not limited to radiation sensitivity syndromes such as xeroderma pigmentosum and ataxia telangiectasia mutated
+Lack of contraindications to systemic immunotherapy (see list of exclusions below)
+Patients with anticipated contraindications to interval tumor reductive surgery
+Is ineligible for an operation based on medical or oncologic contraindications to surgery
+Any contraindications to MRI (eg, participants with pacemakers, claustrophobia, excessive weight, etc).
+Medical contraindications to thoracic irradiation
+No contraindications to the study medications or uncontrolled medical illness
+No contraindications for leukapheresis
+No contraindications for leukapheresis
+PHASE II: No contraindications to MRI
+Contraindications to MRI, including claustrophobia, metallic implants, and pacemakers
+Contraindications for transdermal nicotine patch therapy (TNP)
+Medical oncology examination to evaluate medical contraindications prior to start chemotherapy
+Any known contraindications to cyclophosphamide, fludarabine, etoposide, bendamustine, cetuximab or tocilizumab
+Any known contraindications to cyclophosphamide, fludarabine, etoposide, cetuximab or tocilizumab
+Have contraindications to receiving doxorubicin hydrochloride (HCl).
+No contraindications for leukapheresis
+Subjects who have contraindications to carboplatin, melphalan, etoposide phosphate, or sodium thiosulfate
+Subjects who have contraindications to carboplatin, cyclophosphamide, etoposide phosphate, or sodium thiosulfate
+No contraindications to protocol chemotherapy.
+Any contraindications for ipilimumab (Yervoy) or nivolumab (Opdivo) as per the package inserts.
+Contraindications to MRI such as non-MRI-compatible implanted devices
+mCRC currently not amenable to surgical intervention due to either medical contraindications or non-resectability of the tumor.
+Subjects who have contraindications to carboplatin, melphalan, or STS
+No contraindications to breast MRI
+Medical contraindications to esophagectomy
+Any contraindications to pegylated or non-pegylated interferon
+Any contraindications to pegylated interferon or hydroxyurea
+Patients undergoing breast conservation therapy (i.e. lumpectomy) must not have any contraindications to radiation therapy
+Contraindications to angiography and selective visceral catheterization such as bleeding diathesis or coagulopathy that is not correctable by usual therapy of hemostatic agents
+Allergy or contraindications to administration of the GI anti-spasmodic drug:
+Contraindications to angiography and selective visceral catheterization
+Contraindications for doxorubicin administration
+MRI contraindications.
+Contraindications to angiography and selective visceral arterial catheterization
+Patients undergoing breast conservation therapy (i.e. lumpectomy) must not have any contraindications to radiation therapy
+No contraindications for leukapheresis
+Contraindications to administration of bortezomib
+E . Contraindications to the use of corticosteroid treatment.
+Any contraindications to irradiation
+Contraindications for doxorubicin administration.
+Contraindications to angiography or selective visceral catheterization
+Any medical contraindications for chemotherapy
+Contraindications to the use of corticosteroid treatment.
+Patients with a malignancy that is currently not amenable to surgical intervention due to either medical contraindications or non-resectability of the tumor.
+Contraindications to steroid use
+Locally advanced basal cell carcinoma lesion that is considered to be inoperable or to have medical contraindications to surgery
+Patients with a malignancy that is currently not amenable to surgical intervention, due to either medical contraindications or non-resectability of the tumor.
+Contraindications to exercise
+Major contraindications to anamorelin e.g. hypersensitivity
+In the opinion of the surgeon, the subject has no medical contraindications to pancreatectomy
+In the opinion of the surgeon, the subject has medical contraindications to pancreatectomy
+Standard general contraindications to ERCP or PTBD (e.g. hemodynamic instability, uncorrected coagulopathy).
+Absolute contraindications by pulmonary function testing
+In the opinion of the surgeon, the subject has no medical contraindications to distal pancreatectomy
+In the opinion of the surgeon, the subject has medical contraindications to distal pancreatectomy
+No contraindications to undergo MRI
+Contraindications to MRI
+Patients should have no contraindications to having a contrast enhanced MRI scan; these contraindications will be assessed at the time of enrollment using the guidelines set up and in clinical use by the Radiology Department
+Medical contraindications to undergoing endoscopy or obstruction of the gastrointestinal (GI) tract that precludes passage of the endoscope
+Patients with contraindications to MRI will not be enrolled
+Medical contraindications to blood draw (e.g., hemophilia)
+Patients with contraindications to CEUS
+Patients with contraindications to both CT and MRI
+Has known contraindications to MRI
+Subjects with contraindications to MRI
+With contraindications to MRI examinations as per standard screening guidelines used in the Department of Radiology (i.e., ferromagnetic material or implants, pacemakers or defibrillators, stents, claustrophobia)
+Patients with standard contraindications to MRI, including claustrophobia and metallic implants incompatible with MRI
+Subjects with contraindications to the use of [F] FAZA including confirmed allergy.
+Patients with contraindications for MRI due to embedded foreign metallic objects. Bullets, shrapnel, metalwork fragments, or other metallic material adds unnecessary risk to the patient
+Contraindications for MRI or GBCA (standard of care)
+Subjects with contraindications for receiving HIDA scans and MRI scans will not be eligible to participate in this study
+No contraindications to getting contrast enhanced MRI examinations
+Patients with contraindications for MRI due to embedded foreign metallic objects; bullets, shrapnel, metalwork fragments, or other metallic material adds unnecessary risk to the patient
+Contraindications to undergo MRI
+Patient has no contraindications to the MRI
+Contraindications for MRI (e.g. cardiac pacemaker)
+Contraindications for MRS (e.g. history of abdomino-perineal resection of rectum)
+Patients with contraindications for MRI
+Medical contraindications to esophagectomy
+No obvious contraindications for primary chemotherapy
+Contraindications to TRUS prostrate biopsy
+Participant must not have any contraindications to MRI scanning
+Patient must not have any medical contraindications to MRI (e.g., unsafe foreign metallic implants, incompatible pacemaker, inability to lie still for long periods, severe to end-stage kidney disease or on hemodialysis)
+Contraindications for MRI
+Patients should have no contraindications to having a contrast enhanced MRI scan; these contraindications will be assessed at the time of enrollment using the guidelines set up and in clinical use by the Radiology Department
+Contraindications for MRI
+Subjects with contraindications to MRI
+Contraindications to fMRI, including severe claustrophobia, presence of tissue expanders for breast reconstruction, and presence of a port-a-cath that is incompatible with MRI
+Participants with standard contraindications to non-contrast MRI will be excluded, including claustrophobia and metallic implants incompatible with MRI
+Patients with contraindications to having a contrast enhanced MRI scan